Kayitalire Louis
Chief Medical Officer at Spring Bank Pharmaceuticals, Inc.
- Sold, on record
- $10k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Nov 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Spring Bank Pharmaceuticals, Inc.Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not statedJul 2, 2021 2021
Sold 1,054 shares at $8.43 ($9k)
Kayitalire Louis, Chief Medical Officer
Sold 1.9% of holdings ($467k position)54,383 shares leftFirst sale on recordFiling
- 2 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not statedOct 4, 2021 +94 days
Sold 64 shares at $7.23 ($463)
Kayitalire Louis, Chief Medical Officer
Sold 0.1% of holdings ($393k position)54,319 shares leftFiling
- 3 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not statedNov 2, 2021 +29 days
Sold 64 shares at $6.83 ($437)
Kayitalire Louis, Chief Medical Officer
Sold 0.1% of holdings ($371k position)54,255 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Nov 4, 2021 | Spring Bank Pharmaceuticals, Inc. | Chief Medical Officer | Form 4 sale | 64 | $437 | 0.1% | Plan not stated | SEC |
| Oct 4, 2021 | Oct 6, 2021 | Spring Bank Pharmaceuticals, Inc. | Chief Medical Officer | Form 4 sale | 64 | $463 | 0.1% | Plan not stated | SEC |
| Jul 2, 2021 | Jul 7, 2021 | Spring Bank Pharmaceuticals, Inc. | Chief Medical Officer | Form 4 sale | 1,054 | $9k | 1.9% | Plan not stated | SEC |